Abstract
This paper describes the pathobiology of some of the more common skull base tumors. In addition to clinicopathologic features, emphasis is placed upon methods of diagnosis utilizing immunoperoxidase stains and molecular markers that may or may not impact upon prognosis.
Similar content being viewed by others
References
Bremer JW, Neel HB III, DeSanto LW, Jones GC: Angio-fibroma: Treatment trends in 150 patients during 40 years. Laryngoscope 96: 1321–1329, 1986
Harrison DFN: The natural history, pathogenesis, and treatment of juvenile angiofibroma. Personal experience with 44 patients. Arch Otolaryngol Head Neck Surg 113: 936–942, 1987
Sarpa JR, Novelly NJ: Extranasopharyngeal angiofibroma. Otolaryngol Head Neck Surg 101: 693–697, 1989
Cummings BJ: Relative risk factors in the treatment of juvenile nasopharyngeal angiofibroma. Head Neck Surg 3: 21–26, 1980
Goepfert H, Cangir A, Lee Y-Y: Chemotherapy for aggressive juvenile nasopharyngeal angiofibroma. Arch Otolaryngol 111: 285–289, 1985
Wit TR, Shah JP, Sternberg SS: Juvenile nasopharyngeal angiofibroma. A 30 year clinical review. Am J Surg 146: 521–525, 1983
Johns ME, MacLeod RM, Cantrell RW: Estrogen receptors in nasopharyngeal angiofibromas. Laryngoscope 90: 628–634, 1980
Lee DA, Rao BR, Meyer JS, Prioleau PG, Bauer WC: Hormonal receptor determination in juvenile nasopharyngeal angiofibromas. Cancer 46: 547–551, 1980
Farag MM, Chanimah SE, Ragaie A, Saleem TH: Hormonal receptors in juvenile nasopharyngeal angiofibroma. Laryngoscope 97: 208–211, 1987
Brentani MM, Butugan O, Oshima CTF, Torloni H, Paiva LJ: Multiple steroid receptors in nasopharyngeal angiofibromas. Laryngoscope 99: 398–401, 1989
Gowan AM, Morihara J, Davie P, Donato E, Evans T, Yuan S, Mills SE: Androgen receptor (AR) expression in angiofibromas of the nasopharynx (abstract). Mod Pathol 6: 81A, 1993
Schiff M, Gonzalez A-M, Ong M, Baird A: Juvenile nasopharyngeal angiofibroma contain angiogenic growth factor: Basic FGF. Laryngoscope 102: 940–945, 1992
Barnes L, Weber PC, Krause J, Contis L, Janecka I: Angio-fibroma: A flow cytometric evaluation of 31 cases. Skull Base Surg 2: 195–198, 1992
Makek MS, Andrews JC, Fisch U: Malignant transformation of a nasopharyngeal angiofibroma. Laryngoscope 99: 1088–1092, 1989
Dickson RI: Nasopharyngeal carcinoma: An evaluation of 209 patients. Laryngoscope 91: 333–354, 1981
Simons MJ, Day NE, Wee GB, Shanmugaratnam K, Ho HC, Wong SH, Ti TK, Yong NK, Darmalingam S, de-The G: Nasopharyngeal carcinoma V: Immunogenetic studies of Southeast Asian ethnic groups with high and low risk for the tumor. Cancer Res 34: 1192–1195, 1974
Chan SH, Day NE, Khor TH, Kunaratnam N, Chia KB: HLA markers in the development and prognosis of NPC in Chinese. In: Grundmann E, Krueger GRF, Ablashi DV (eds) Nasopharyngeal Carcinoma. Gustav Fischer Verlag, Stuttgart 205–211, 1981
Zhu X, Chen R, Kong F, Liu W: Human leukocyte antigens -A, -B, -C, and -DR and nasopharyngeal carcinoma in northern China. Ann Otol Laryngol 99: 286–287, 1990
Betuel H, Camoun M, Colombani J, Day NE, Ellouz R, de-The G: The relationship between nasopharyngeal carcinoma and the HLA system among Tunisians. Int J Cancer 16: 249–254, 1975
Moore SB, Pearson GR, Neel HB III, Weiland LH: HLA and nasopharyngeal carcinoma in North American Caucasoids. Tissue Antigens 22: 72–75, 1983
Lanier A, Bender T, Talbot M, Wilmeth S, Tschopp C, Henle W, Henle G, Ritter D, Terasaki P: Nasopharyngeal carcinoma in Alaskan Eskimos, Indians, and Aleuts: A review of cases and study of Epstein-Barr virus, HLA, and environmental risk factors. Cancer 46: 2100–2106, 1980
Raab-Traub N, Flynn K, Pearson G, Huang A, Levine P, Lanier A, Pagano J: The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA. Int J Cancer 39: 25–29, 1987
Hawkins EP, Krischer JP, Smith BE, Hawkins HK, Finegold MJ: Nasopharyngeal carcinoma in children — A retrospective review and demonstration of Epstein-Barr viral genomes in tumor cell cytoplasm: A report of the Pediatric Oncology Group. Hum Pathol 21: 805–810, 1990
Neel HB III, Taylor WF: Epstein-Barr virus-related anti-body. Changes in titers after therapy for nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 116: 1287–1290, 1990
Lung ML, Sham JST, Lam WP, Choy DTK: Analysis of Epstein-Barr virus in localized nasopharyngeal carcinoma tumors. Cancer 71: 1190–1192, 1993
Zur Hausen H, Schulte-Hosthausen H, Klein G: EBV DNA in biopsies of Burkitt tumors and anaplastic carcinomas of the nasopharynx. Nature 228: 1056–1058, 1970
Huang DP, Ho HC, Henle G: Presence of EBNA in nasopharyngeal carcinoma and control patient tissues related to EBV serology. Int J Cancer 22: 266–274, 1978
Armstrong RW, Armstrong MJ, Yu MC, Henderson BE: Salted fish and inhalants as risk factors for nasopharyngeal carcinoma in Malaysian Chinese. Cancer Res 43: 2967–2970, 1983
Sham JST, Choy D: Prognostic factors of nasopharyngeal carcinoma: A review of 759 patients. Br J Radiol 63: 51–58, 1990
Skinner DW, Van Haslett CA, Tsao SY: Nasopharyngeal carcinoma: modes of presentation. Ann Otol Rhinol Laryngol 100: 549–551, 1991
Sham JST, Cheung YK, Choy D, Chan FL, Leong L: Cranial nerve involvement and base of the skull erosion in nasopharyngeal carcinoma. Cancer 68: 422–426, 1991
Gustafson RO, Neel HB III: Cancer of the nasopharynx. In: Myers EN, Suen JY (eds) Cancer of the Head and Neck, 2nd ed, Churchill Livingston 495–508, 1989
Ahmad A, Stefani S: Distant metastases of nasopharyngeal carcinoma: A study of 256 patients. J Surg Oncol 33: 194–197, 1981
Vikram B, Mishra UB, Strong EW, Manolatos S: Patterns of failure in carcinoma of the nasopharynx: Failure at distant sites. Head Neck Surg 8: 276–279, 1986
Feinmesser R, Feinmesser M, Freeman JL, Noyek AM, Livni N: Detection of occult nasopharyngeal primary tumours by means ofin situ hybridization. J Laryngol Otol 106: 345–348, 1992
Feinmesser R, Miyazakai I, Cheung R, Freeman JL, Noyek AM, Dosch H-M: Diagnosis of nasopharyngeal carcinoma by DNA amplification of tissue obtained by fine-needle aspiration. N Engl J Med 326: 17–21, 1992
Shanmugaratnam K, Sobin L: Histologic Typing of Upper Respiratory Tract Tumors. International Typing of Tumours No. 19. World Health Organization, Geneva, 1978
Shanmugaratnam K, Sobin L: Histological Typing of Tumours of the Upper Respiratory Tract and Ear. International Histological Classification of Tumours, 2nd. ed., Springer-Verlag, Berlin, 1991
Weiland LH: Nasopharyngeal carcinoma. In: Barnes L (ed) Surgical Pathology of the Head and Neck, Marcel Dekker Inc, New York 453–466, 1985
Shanmugaratnam K, Chan SH, de-The G, Goh JEH, Khor TH, Simons MJ, Tye CY: Histopathology of nasopharyngeal carcinoma. Correlations with epidemiology, survival rates and other biological characteristics. Cancer 44: 1029–1044, 1979
Weiss LM, Movahed LA, Butler AE, Swanson SA, Frierson HF Jr, Cooper PH, Colby TV, Mills SE: Analysis of lymphoepithelioma-like carcinoma for Epstein-Barr viral genomes byin-situ hybridization. Am J Surg Pathol 13: 625–631, 1989
Akoa I, Sato Y, Mukai K, Uhara H, Furuya S, Hoshikawa T, Shimosato Y, Takeyama I: Detection of Epstein-Barr virus DNA in formalin-fixed paraffin-embedded tissue of nasopharyngeal carcinoma using polymerase chain reaction andin situ hybridization. Laryngoscope 101: 279–283, 1991
Nomori H, Watanabe S, Nakajima T, Shimosato Y, Kameya T: Histiocytes in nasopharyngeal carcinoma in relation to prognosis. Cancer 57: 100–105, 1986
Hsu M-M, Hsu H-C, Lui LT: Local immune reaction in nasopharyngeal carcinoma, with special reference to its prognostic evaluation. Head Neck 11: 505–510, 1989
Cheng DS, Campbell BH, Clowry LJ, Hopwood LE, Murray KJ, Toohill RJ, Hoffman RG: DNA content in naso-pharyngeal carcinoma. Am J Otolaryngol 11: 393–397, 1990
Costello F, Mason BR, Collins RJ, Kearsley JH: A clinical and flow cytometric analysis of patients with nasopharyngeal carcinoma. Cancer 66: 1789–1795, 1990
Neel HB III, Taylor WF, Pearson GR: Prognostic determinants and a new view of staging for patients with nasopharyngeal carcinoma. Ann Otol Rhinol Laryngol 94: 529–537, 1985
Cooper JS, Scott C, Marcial V, Griffin T, Fazekas J, Laramore G, Hoffman A: The relationship of nasopharyngeal carcinomas and second independent malignancies based on the Radiation Therapy and Oncology Group. Cancer 67: 1673–1677, 1991
Singh P, Ilancheran A, Ratnam SS, Kim L-TS, O'Reilly AP: Cervical adenocarcinoma in women with nasopharyngeal carcinoma (NPC). Cancer 64: 1152–1155, 1989
Kavanagh BD, Halperin EC, Rosenbaum LC, Shannon EM, Nilaver G: Syndrome of inappropriate secretion of antidiuretic hormone in a patient with carcinoma of the nasopharynx. Cancer 69: 1315–1319, 1992
Choi PHK, Suen MWM, Huang DP, Lo K-W, Lee JC: Nasopharyngeal carcinoma: Genetic changes, Epstein-Barr virus infection, or both. A clinical and molecular study of 36 patients. Cancer 72: 2873–2878, 1993
Cianfriglia F, Pompili A, Occhipinti E: Intracranial malignant cartilaginous tumours. Report of two cases and review of the literature. Acta Neurochirurgica 45: 163–175, 1978
Bahr AL, Gayler BW: Cranial chondrosarcomas. Report of four cases and review of the literature. Radiology 124: 151–156, 1977
Hassounah M, Al-Mefty O, Akhtar M, Jinkins JR, Fox JL: Primary cranial and intracranial chondrosarcoma. A survey. Acta Neurochirurgica 78: 123–132, 1985
Kveton JF, Brackman DE, Glasscock ME III, House WF, Hitselberger WE: Chondrosarcoma of the skull base. Otolaryngol Head Neck Surg 94: 23–32, 1986
Austin-Seymour M, Munzenrider J, Goitein M, Verhey L, Urie M, Gentry R, Birbaum S, Ruotolo D, McManus P, Skates S, Ojemann RG, Rosenberg A, Schiller A, Koehler A, Suit HD: Fractionated proton radiation therapy of chordoma and low-grade chondrosarcoma of the base of the skull. J Neurosurg 70: 13–17, 1989
Morimoto T, Sasaki T, Tokakura K, Ishida T: Chondrosarcoma of the skull base: Report of six cases. Skull Base Surg 2: 177–185, 1992
Adegbite ABO, McQueen JD, Paine KWE, Rozdilsky B: Primary intracranial chondrosarcoma: A report of two cases. Neurosurgery 17: 490–494, 1985
Grossman RI, Davis KR: Cranial computed tomographic appearance of chondrosarcoma of the base of the skull. Radiology 141: 403–108, 1981
Sen CN, Sekhar LN, Schramm VL, Janecka IP: Chordoma and chondrosarcoma of the cranial base: An 8-year experience. Neurosurgery 25: 931–941, 1989
Evans HL, Ayala AG, Romsdahl MM: Prognostic factors in chondrosarcoma of bone. A clinicopathologic analysis with emphasis on histologic grading. Cancer 40: 818–831, 1977
Kreicbergs A, Boquist L, Boxssen B, Larsson S-E: Prognostic factors in chondrosarcoma. A comparative study of cellular DNA content and clinicopathologic features. Cancer 50: 577–583, 1982
Mandahl N, Heim S, Arheden K, Rydholm A, Willen H, Mitelman F: Chromosomal rearrangements in chondromatous tumors. Cancer 65: 242–248, 1990
Wright D: Nasopharyngeal and cervical chordoma — some aspects of their development and treatment. J Laryngol Otol 81: 1337–1355, 1967
Huvos AG: Chordoma. In: Huvos AG (ed) Bone Tumors. Diagnosis, Treatment and Prognosis, 2nd ed., WB Saunders, Philadelphia 599–624, 1991
Heffelfinger MJ, Dahlin DC, MacCarty SS, Beabout JW: Chordomas and cartilaginous tumors at the skull base. Cancer 32: 410–420, 1973
Raffel C, Wright DC, Gutin PH, Wilson CB: Cranial chordomas: clinical presentation and results of operative and radiation therapy in twenty-six patients. Neurosurgery 17: 703–709, 1985
Meyer JE, Oot RF, Lindfors KK: CT appearance of clival chordomas. J Comput Assist Tomogr 10: 34–38, 1986
Wold LE, Laws ER Jr: Cranial chordomas in children and young adults. J Neurosurg 59: 1043–1047, 1983
Oot RF, Melville GE, New PFJ, Austin-Seymour M, Munzenrider J, Pile-Spellman J, Spagnoli M, Shoukimas GM, Momose KJ, Carroll R, Davis KR: The role of MR and CT in evaluating clival chordomas and chondrosarcomas. AJR 151: 567–575, 1988
O'Neill P, Bell BA, Miller JD, Jacobson I, Guthrie W: Fifty years of experience with chordomas in Southeast Scotland. Neurosurgery 16: 166–170, 1985
Crumley RL, Gutin PH: Surgical access for clivus chordoma. Arch Otolaryngol Head Neck Surg 115: 295–300, 1989
Harbour JW, Lawton MT, Criscuolo GR, Holliday MJ, Mattox DE, Long DM: Clivus chordoma: A report of 12 recent cases and review of the literature. Skull Base Surg 1: 200–206, 1991
Chambers PW, Schwinn CP: Chordoma. A clinicopathologic study of metastasis. Am J Clin Pathol 72: 765–776, 1979
Coffin CM, Swanson PE, Wick MR, Dehner LP: Chordoma in childhood and adolescence. A clinicopathologic analysis of 12 cases. Arch Pathol Lab Med 117: 927–933, 1993
Wold LE, Laws ER Jr: Cranial chordomas in children and young adults. J Neurosurg 59: 1043–1047, 1983
Hruban RH, Tragnanos F, Reuter VE, Huvos AG: Chordomas with malignant spindle cell components. A DNA flow cytometric and immunohistochemical study with histogenetic implications. Am J Pathol 137: 435–447, 1990
Chu T-A: Chondroid chordoma of the sacrococcygeal region. Arch Pathol Lab Med 111: 861–864, 1987
Volpe R, Mazabraud A: A clinicopathologic review of 25 cases of chordoma (a pleomorphic and metastasizing neoplasm). Am J Surg Pathol 7: 161–170, 1983
Rich TA, Schiller A, Suit HD, Mankin JH: Clinical and pathologic review of 48 cases of chordoma. Cancer 56: 182–187, 1985
Perzin KH, Pushparaj NL: Nonepithelial tumors of the nasal cavity, paranasal sinuses, and nasopharynx. A clinico-pathologic study. XIV: Chordomas. Cancer 57: 784–796, 1986
Brooks JJ, Livolsi VA, Trojanowski JQ: Does chondroid chordoma exist? Acta Neuropathologica 72: 229–235, 1987
Wojno KJ, Hurban RH, Garin-Chesa P, Huvos AG: Chondroid chordomas and low-grade chondrosarcomas of the craniospinal axis. An immunohistochemical analysis of 17 cases. Am J Surg Pathol 16: 1144–1152, 1992
Miettinen M, Karaharju E, Jarvinen H: Chordoma with a massive spindle-cell sarcomatous transformation. A light- and electron-microscopic and immunohistochemical study. Am J Surg Pathol 11: 563–570, 1987
Meis JM, Raymond AK, Evans HL, Charles RE, Giraldo AA: ‘Dedifferentiated” chordoma. A clinicopathologic and immunohistochemical study of three cases. Am J Surg Pathol 11: 516–525, 1987
Fleming GF, Heimann PS, Stephens JK, Simon MA, Ferguson MK, Benjamin RS, Samuels BL: Dedifferentiated chordoma. Response to aggressive chemotherapy in two cases. Cancer 72: 714–718, 1993
Al-Mefty O (ed): Meningiomas. Raven Press Ltd, NewYork 37–57, 1991
Barnes L, Peel RL, Verbin R: Tumors of the nervous system. In: Barnes L (ed) Surgical Pathology of the Head and Neck, Marcel Dekker, Inc, New York, New York 659–724, 1985
Gagon NB, Lavigne F, Mohr G,et al.: Extracranial and intracranial meningiomas. J Otolaryngol 15: 380–384, 1986
Kepes JJ: Meningioma — Biology, Pathology and Differential Diagnosis, Masson Publishing Inc, Philadelphia, USA, 1982
Winek RR, Scheithauer BW, Wick MR: Meningioma, meningeal hemangiopericytoma (angioblastic meningioma), peripheral hemangiopericytoma and acoustic schwannoma. Am J Surg Pathol 13: 251–261, 1989
Nager GT, Heroy J, Hoeplinger M: Meningiomas invading the temporal bone with extension to the neck. Am J Otolaryngol 4: 197–324, 1983
Goellner JR, Laws ER, Soule EH,et al.: Hemangiopericytoma of the meninges. Mayo Clinic experience. Am J Clin Pathol 70: 375–380, 1978
Holden J, Dolman CL, Churg A: Immunohistochemistry of intracranial meningiomas including angioblastic type. J Neuropathol Exp Neurol 46: 50–56, 1987
Meis JM, Ordonez NG, Bruner JM: Meningiomas. An immunohistochemical study of 50 cases. Arch Pathol Lab Med 110: 934–937, 1986
Radley MG, Sant'Agnese AD, Eskin TA,et al.: Epithelial differentiation in meningiomas. An immunohistochemical, histochemical, and ultrastructural study with review of the literature. Am J Surg Pathol 92: 226–272, 1989
Schnitt SJ, Vogel H: Meningiomas. Diagnostic value of immunoperoxidase staining for epithelial membrane antigen. Am J Surg Pathol 10: 640–649, 1986
Suster S, Rosai J: Hamartoma of the scalp with ectopic meningothelial elements. A distinctive benign soft tissue lesion that may simulate angiosarcoma. Am J Surg Pathol 14: 1–14, 1990
Thomas HG, Dolman CI, Berry K: Malignant meningiomas: clinical and pathological features. J Neurosurg 55: 929–934, 1981
Friedman CD, Costantino PD, Teitelbaum B,et al.: Primary extracranial meningiomas of the head and neck. Laryngoscope 100: 41–48, 1990
Batsakis JG: Extracranial meningiomas. Ann Otol Rhinol Laryngol 93: 282–283, 1984
Manni JJ; Ectopic meningioma of the maxillary sinus. J Laryngol Otol 97: 657–660, 1983
Perzin KH, Pushparaj N: Nonepithelial tumors of the nasal cavity, paranasal sinuses, nasopharynx. A clinicopathologic study. XIII: Meningiomas. Cancer 54: 1860–1869, 1984
Salama N, Stafford N: Meningiomas presenting in the middle ear. Laryngoscope 92: 92–97, 1982
Taxy JB: Meningioma of the paranasal sinuses. A report of two cases. Am J Surg Pathol 14: 82–86, 1990
Cahill DW, Bashirelahi N, Solomon LW,et al: Estrogen and progesterone receptors in meningiomas. J Neurosurg 60: 985–993, 1984
Lesch K-P, Gross SG: Estrogen receptor immunoreactivity in meningiomas. Comparison with the binding activity of estrogen, progesterone, and androgen receptors. J Neurosurg 67: 237–243, 1987
Casalone R, Simi P, Granata P,et al.: Correlation between cytogenetic and histopathologic findings in 65 human meningiomas. Cancer Genet Cytogenet 45: 237–243, 1990
Jones NR, Rossi ML, Gregoriou M,et al: Epidermal growth factor receptor expression in 72 meningiomas. Cancer 66: 152–155, 1990
Shiurba RA, Eng LF, Vogel H,et al. Epidermal growth factor receptor in meningiomas is expressed predominantly on endothelial cells. Cancer 62: 2139–2144, 1988
Salmon I, Kiss R, Lavivier M,et al: Characterization of nuclear DNA content, proliferation index, and nuclear size in a series of 181 meningiomas, including benign primary, recurrent, and malignant tumors. Am J Surg Pathol 17: 239–247, 1993
Ironside JW, Battersby RDE, Lawry J,et al: DNA in meningioma tissues and expiant cell cultures: a flow cytometric study with clinicopathologic correlates. J Neurosurg 66: 588–594, 1987
Hoshino T, Nagashima T, Murovic JA,et al.: Proliferative potential of human meningiomas of the brain. A cell kinetics study with bromodeoxyuridine. Cancer 58: 1466–1472, 1986
Korkolopoulou P, Christodoulou A, Papanikolaou A, Thomas-Tsagli E: Proliferating cell nuclear antigen and nucleolar organizer regions in CNS tumors: correlation with histological type and tumor grade. A comparative study of 82 cases on paraffin sections. Am J Surg Pathol 17: 912–919, 1993
Patsouris E, Stocker U, Kallmeyer V,et al.: Relationship between Ki-67 positive cells, growth rate and histologic type of human intracranial tumors. Anticancer Res 8: 537–544. 1988
Roggendorf W, Schuster T, Peiffer J: Proliferative potential of meningiomas determined with the monoclonal anti-body Ki-67. Acta Neuropathol (Berl) 73: 361–364, 1987
Fukui M, Iwaki T, Sawa H,et al: Proliferative activity of meningiomas as evaluated by bromodeoxyuridine uptake examination. Acta Neurochir (Wien) 81: 135–141, 1986
Scheithauer BW: Surgical Pathology of the Pituitary: The adenomas (Parts 1 and 2). Pathol Annu 19: 269–329, and 317–374, 1984
Scheithauer BW: The anterior pituitary hormones with special reference to the immunocytology of pituitary adenomas and neuroendocrine neoplasms. In: Wick MR, Seigal GP (eds) Monoclonal Antibodies in Diagnostic Immunohistochemistry, Marcel Dekker, New York, 1988
Kovacs K, Horvath E: Tumors of the pituitary gland. In: Atlas of Tumor Pathology, 2nd Series, Fascicle 21, Washington, DC, Armed Forces Institute of Pathology, 1986
Martinez AJ, Lee A, Moossy J, Maroon JC: Pituitary adenomas: Clinico-pathologic and immunohistochemical study. Ann Neurol 7: 24–36, 1980
Challa VR, Marshall RB, Hopkins MB,et al.: Pathobiologic study of pituitary tumors: report of 62 cases with a review of the recent literature. Hum Pathol 16: 873–884, 1985
Anand VK, Osborne CM, Harkey L: Infiltrative clival pituitary adenoma of ectopic origin. Otolaryngol Head Neck Surg 108: 178–183, 1993
Chessin H, Urdaneta N, Smith H, Gilder JV: Chromo-phobe adenoma manifesting as a nasopharyngeal mass. Arch Otolaryngol 102: 631–633, 1976
Cole IE, Keene M: Nasal obstruction in pituitary tumors. J Laryngol Otol 95: 183–189, 1981
Davis JM, Weber AL: Pituitary adenoma presenting as a sphenoid sinus lesion. Ann Otol Rhinol Laryngol 89: 483–484, 1980
Dent JA, Rickhuss PK: Invasive pituitary adenoma presenting with nasal obstruction. J Laryngol Otol 103: 605–609, 1989
Scheithauer BW, Kovacs K, Laws ER, Randall RV: Pathology of invasive pituitary tumors with special reference to functional classification. J Neurosurg 65: 733–744, 1986
Alexander JM, Biller BMK, Bikkal H,et al.: Clinically non-functioning pituitary tumors are monoclonal in origin. J Clin Invest 86: 336–340, 1990
Black PM, Hus DW, Klibanski A,et al.: Hormone production in clinically non-functioning pituitary adenomas. J Neurosurg 66: 244–250, 1987
Flickinger JC, Nelson PB, Martinez AJ,et al: Radiotherapy of nonfunctional adenomas of the pituitary gland. Results with long-term follow-up. Cancer 63: 2409–2414, 1989
Martinez AJ: The pathology of nonfunctional pituitary adenomas. Semin Diagn Pathol 3: 83–94, 1986
Kovacs K, Horvath E, Ryan N,et al.: Null cell adenoma of the human pituitary. Virchows Archiv [A] Pathol Anat 387: 165–174, 1980
Lloyd RV, Chandler WF, Kovacs K, Ryan N: Ectopic pituitary adenomas with normal pituitary glands. Am J Surg Pathol 10: 546–552, 1986
Mukai K: Pituitary adenomas. Immunocytochemical study of 150 tumors with clinicopathologic correlation. Cancer 52: 648–653, 1983
Scheithauer BW, Randall RV, Laws ERJ,et al: Prolactin cell carcinoma of the pituitary. Clinicopathologic, immunohistochemical, and ultrastructural study of a case with cranial and extracranial metastases. Cancer 55: 598–604, 1985
Lloyd RV, Cano M, Chandler WF,et al: Human growth hormone and prolactin secreting pituitary adenomas analyzed by in situ hybridization. Am J Pathol 134: 605–613, 1989
Levy A, Lightman SL: Quantitativein-situ hybridization histochemistry of anterior pituitary hormone mRNA species in human pituitary adenomas. Acta Endocrinol 119: 397–404, 1988
Fitzgibbons PL, Appley AJ, Turner RR,et al.: Flow cytometry analysis of pituitary tumors. Correlation of nuclear antigen pl05 and DNA content with clinical behavior. Cancer 62: 1156–1560, 1988
McNicol AM, Shepherd M, Lane DP: Cell proliferation in pituitary adenomas: corrrelation with hormonal immuno-reactivity. J Endocrinol Invest 14 (Suppl 1): 1991A, 1991
Nagashima T, Murovic JA, Hoshino T,et al.: The proliferative potential of human pituitary tumorsin situ. J Neuro-surg 64: 588–593, 1986
Herman V, Fagin J, Gonskyet al.: Clonal origin of pituitary adenomas. J Clin Endocrinol Metab 71: 1427–1433, 1990
Landis CA, Masters SB, Spada A, et al: Clonal origin of pituitary adenomas. J Clin Endocrinol Metab 71: 1427–1433, 1990
Karga HJ, Alexander JM, Hedley-Whyte ET,et al: Ras mutations in human pituitary tumors. J Clin Endocrinol Metab 74: 914–919, 1992
Stefaneanu L, Horvath E, Kovacs K: Argyrophil organizer region proteins (AgNORs) in adenohypophysial cells and adenomas of the human pituitary. Mod Pathol 2: 192–199, 1989
Appelblatt NH, McClatchey KD: Olfactory neuroblastoma: A retrospective clinicopathologic study. Head Neck Surg 5: 108–113, 1982
Baker DC, Perzin KH, Conley J: Olfactory neuroblastoma. Otolaryngol Head Neck Surg 87: 279–283, 1979
Barnes L, Peel RL, Verbin RS: Tumors of the nervous system. In: Barnes L (ed) Surgical Pathology of the Head and Neck, Vol 1, Marcel Dekker, Inc, New York 659–724, 1985
Dulguerov P, Calcaterra T: Esthesioneuroblastoma: The UCLA experience 1970–1990. Laryngoscope 102: 843–849, 1992
Elkon D, Hightower SI, Lim ML, Cantrell RW, Constable WC: Esthesioneuroblastoma. Cancer 44: 1087–1094, 1979
Harrison D: Surgical pathology of olfactory neuroblastoma. Head Neck Surg 7: 60–64, 1984
Hyams VJ, Batsakis JG, Michaels L: Tumors of the Upper Respiratory Tract and Ear. Atlas of Tumor Pathology, Armed Forces Institute of Pathology, 1988
Kadish S, Goodman M, Wang CC: Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer 37: 1571–1576, 1976
Lewis JE, Morita A, Ebersold MJ: Grading and prognosis of olfactory neuroblastoma. Mod Pathol 6: 82A, 1993
Lund VJ, Milroy C: Olfactory neuroblastoma: clinical and pathological aspects. Rhinology 31: 1–6, 1993
Mills SE, Frierson HF Jr: Olfactory neuroblastoma. A clinicopathologic study of 21 cases. Am J Surg Pathol 9: 317–327, 1985
Olsen KD, DeSanto LW: Olfactory neuroblastoma. Biologic and clinical behavior. Arch Otolaryngol 109: 797–802, 1983
Taxy JB, Bharani NK, Mills SE,et al: The spectrum of olfactory neural tumors. A light-microscopic, immunohisto-chemical, and ultrastructural analysis. Am J Surg Pathol 10: 687–695, 1986
Taxy JB, Hidvegi DF: Olfactory neuroblastoma. An ultra-structural study. Cancer 39: 131–138, 1977
Nakashima T, Kimmelman CP, Snow JB Jr: Structure of human fetal and adult olfactory neuroepithelium. Arch Otolaryngol 110: 641–646, 1984
Schmidt JL, Zarbo RJ, Clark JL: Olfactory neuroblastoma: clinicopathologic and immunohistochemical characterization of four representative cases. Laryngoscope 100: 1052–1058, 1990
Axe S, Kuhajda FP: Esthesioneuroblastoma. Intermediate filaments, neuroendocrine, and tissue-specific antigens. Am J Clin Pathol 88: 139–145, 1987
Choi H-S, Anderson PJ: Immunohistochemical diagnosis of olfactory neuroblastoma. J Neuropathol Exp Neurol 44: 18–31, 1985
Frierson HF, Ross GW, Mills SE,et al: Olfactory neuroblastoma. Additional immunohistochemical characterization. Am J Clin Pathol 94: 547–553, 1990
Trojanowski JQ, Lee V, Pillsbury N,et al.: Neuronal origin of human esthesioneuroblastoma demonstrated with anti-neurofilament monoclonal antibodies. N Eng J Med 307: 159–161, 1982
Barnes L, Peel RL: Olfactory neuroblastomas versus sinonasal undifferentiated carcinoma. In: Head and Neck Pathology. A Text/Atlas of Differential Diagnosis, Igaku-Shoin, New York 152–154, 1990
Baugh RF, Wolf GT, McClatchey KD: Small cell carcinoma of the head and neck. Head Neck Surg 8: 343–354, 1986
Frierson HF, Mills SE, Fechner RE,et al. Sinonasal undifferentiated carcinoma. An aggressive neoplasm derived from Schneiderian epithelium and distinct from olfactory neuroblastoma. Am J Surg Pathol 10: 771–779, 1986
Kameya T, Shimosato Y, Adachi I,et al.: Neuroendocrine carcinoma of the paranasal sinus. A morphological and endocrinological study. Cancer 45: 330–339, 1980
Mills SE, Fechner RE: Differentiated neoplasms of the sinonasal region: Differential diagnosis based on clinical, light microscopic, immunohistochemical, and ultrastructural features. Semin Diag Pathol 6: 316–328, 1989
Silva EG, Butler JJ, Mackay B, Goepfert H: Neuroblastoma and neuroendocrine carcinomas of the nasal cavity. A proposed new classification. Cancer 50: 2388–2405, 1982
Stephenson CF, Bridge JA, Sandberg AA. Cytogenetic and pathogenetic aspects of Ewing's sarcoma and neuroecto-dermal tumors. Hum Pathol 23: 1270–1277, 1992
Whang-Peng J, Freter CE, Knutsen T,et al: Translocation t(11;22) in esthesioneuroblastoma. Cancer Genet Cytogenet 29: 155–157, 1987
Wenig B, Hitchcock C, Griffin J, Heffner D: Olfactory esthesioneuroblastoma: Support for a grading system based on flow cytometric and histopathologic correlation. Mod Pathol 3: 65A, 1990 (abstract)
Schwartz MR, Hicks MJ, SeGall GK, Donovan DT: Flow cytometric analysis of olfactory neuroblastomas and high grade olfactory neuroendocrine carcinomas. Mod Pathol 6: 83A, 1993
Zappia JJ, Carroll WR, Wolf GT, Thornton AF, Ho L, Krause CJ: Olfactory neuroblastoma: The results of modern treatment approaches at the University of Michigan. Head Neck 15: 190–196, 1993
Gould VE, Sommers SC: The adrenal medulla and para-ganglia. In: Bloodworth (ed) Endocrine Pathology, General and Surgical, second edition, Williams and Wilkins, Baltimore 497–511, 1982
Glenner GG, Grimley PM: Tumors of the Extra-adrenal Paraganglion System (Including Chemoreceptors). Atlas of Tumor Pathology, Armed Forces Institute of Pathology, fascicle 9, second series, 1974
Barnes L, Taylor S: Carotid body paragangliomas: a clinicopathologic and DNA analysis of 13 tumors. Arch Otolaryngol 116: 447–453, 1990
Barnes L, Taylor S: Vagal paragangliomas: a clinical, pathological and DNA assessment. Clin Otolaryngol 16: 376–382, 1991
Brown JS: Glomus jugulare tumors revisited: A ten-year statistical follow up of 231 cases. Laryngoscope 95: 284–288, 1985
Erikson C, Girdhar-Gopal H, Lowry LD: Vagal paragangliomas: A report of nine cases. Am J Otolaryngol 12: 278–287, 1991
Kliewer KE, Wen DR, Cancilla PA, Cochran AJ: Paragangliomas: assessment of prognosis by histologic, immuno-histochemical, and ultrastructural techniques. Hum Pathol 20: 29–39, 1989
Kliewer KE, Cochran AJ: A review of the histology, ultrastructure, immunohistology, and molecular biology of extra-adrenal paragangliomas. Arch Pathol Lab Med 113: 1209–1218, 1989
Lack EE, Cubilla AL, Woodruff JM: Paragangliomas of the head and neck region. A clinical study of 69 patients. Cancer 39: 397–409, 1977
Lack EE, Cubilla AL, Woodruff JM: Paragangliomas of the head and neck region. A pathologic study of tumors from 70 patients. Hum Pathol 10: 191–218, 1979
Moore G, Yarington CT, Mangham CA: Vagal body tumors: Diagnosis and treatment. Laryngoscope 96: 533–536, 1986
Johnstone PAS, Foss RD, Desilets DJ: Malignant jugulo-tympanic paraganglioma. Arch Pathol Lab Med 114: 976–979, 1990
Martinez-Madrigal F, Bosq J, Micheau C, Nivet P, Luboinski B: Paragangliomas of the head and neck. Immunohistochemical analysis of 16 cases in comparison with neuroendocrine carcinomas. Pathol Res Prac 187: 814–823, 1991
Warren WH, Lee I, Gould VE,et al.: Paragangliomas of the head and neck: Ultrastructural and immunohistochemical analysis. Ultrastructural Pathol 8: 333–343, 1985
Nadji M, Albores-Saavedra J, Ziegels-Weissman J, Morales AR: Antigenic profile of benign, locally invasive, and metastatic paragangliomas. Lab Invest 54: 46A, 1986
Schroder HD, Johannsen L: Demonstration of S-100 protein in sustentacular cells of pheochromocytomas and paragangliomas. Histopathology 10: 1023–1033, 1986
Achilles E, Padberg BC, Holl K, Kloppel G, Schroder S: Immunocytochemistry of paragangliomas-value of staining for S-100 protein and glial fibrillary acidic protein in diagnosis and prognosis. Histopathology 18: 453–458, 1991
Jackson CG, Harris PF, Glasscock ME, Fritsch M, Dimitrov E, Johnson GD, Poe DS: Diagnosis and management of paragangliomas of the skull base. Am J Surg 159: 389–393, 1990
Kimura N, Miura Y, Nagatsu I, Nagura H: Catecholamine synthesizing enzymes in 70 cases of functioning and non-functioning pheochromocytoma and extra-adrenal paraganglioma. Virchows Arch A Pathol Anat 421: 25–32, 1992
Kremer R, Michel RP, Posner B, Wang NS, Lafond GP, Crawhall JC: Catecholamine-secreting paraganglioma of glomus jugulare region. Am J Med Science 297: 46–48, 1989
Sobol SM, Dailey JC: Familial multiple cervical paragangliomas: report of a kindred and review of the literature. Otolaryngol Head Neck Surg 102: 382–390, 1990
Jovanovic R, Hacker GW, Falkmer UG, Falkmer S, Mendel L, Graf AH, Hoog A, Kanjuh V, Silfversward C, Grimelieu L: Paragangliomas: neuroendocrine features and cytometric DNA distribution patterns. A clinicopathological study of 22 cases. Virchows Arch-A, Pathol Anat Histopathol 419: 455–461, 1991
Van der Mey AG, Cornelisse CJ, Hermans J, Terpstra JL, Schmidt PH, Fleuren GJ: DNA flow cytometry of hereditary and sporadic paragangliomas (glomus tumors). Brit J Cancer 63: 298–302, 1991
Granger JK, Houn HY: Head and neck paragangliomas: a clinicopathologic study with DNA flow cytometric analysis. South Med J 83: 1407–1412, 1990
Gee MS, Kliewer KE, Hinton DR: Nucleolar organizer regions in paragangliomas of the head and neck. Arch Otolaryngol Head Neck Surg 118: 380–383, 1992
Reubi JC, Waser B, Khosla S, Kvols L, Goellner JR, Krenning E, Lamberts S:In vitro andin vivo detection of somatostatin receptors in pheochromocytomas and paragangliomas. J Clin Endocrinol Metab 74: 1082–1089, 1992
Suzuki T, Watanabe K, Sugino T,et al.: Immunocytochemical demonstration of IGF-II immunoreactivity in human phaeochromocytoma and extra-adrenal abdominal para-ganglioma. J Pathol 167: 199–203, 1992
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Barnes, L., Kapadia, S.B. The biology and pathology of selected skull base tumors. J Neuro-Oncol 20, 213–240 (1994). https://doi.org/10.1007/BF01053041
Issue Date:
DOI: https://doi.org/10.1007/BF01053041